Trial intelligence / Profile preview

Furazolidone vs Metronidazole for H. pylori Rescue in Penicillin-Allergic Patients

NCT05135182Phase 4Unknown

Sponsor
Shandong University
Start
Nov 2021
Primary completion
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of furazolidone in Helicobacter pylori infection, sponsored by Shandong University. Status: unknown.

02

Drugs

furazolidone
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT05135182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05135182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call